The Frizzled family of unconventional GPCRs
SCHULTE, G. and Vítězslav BRYJA. The Frizzled family of unconventional GPCRs. Trends in Pharmacological Sciences. 2007, vol. 28, No 10, p. 518-525. ISSN 0165-6147. |
Other formats:
BibTeX
LaTeX
RIS
|
Basic information | |
---|---|
Original name | The Frizzled family of unconventional GPCRs |
Name in Czech | Frizzled : rodina nekonvenčních G-proteinových receptorů |
Authors | SCHULTE, G. (276 Germany) and Vítězslav BRYJA (203 Czech Republic, guarantor). |
Edition | Trends in Pharmacological Sciences, 2007, 0165-6147. |
Other information | |
---|---|
Original language | English |
Type of outcome | Article in a journal |
Field of Study | Genetics and molecular biology |
Country of publisher | United Kingdom of Great Britain and Northern Ireland |
Confidentiality degree | is not subject to a state or trade secret |
Impact factor | Impact factor: 9.610 |
RIV identification code | RIV/00216224:14310/07:00025663 |
Organization unit | Faculty of Science |
UT WoS | 000250635700004 |
Keywords in English | Frizzled; Wnt; signalling mechanism |
Tags | Frizzled, signalling mechanism, Wnt |
Changed by | Changed by: prof. Mgr. Vítězslav Bryja, Ph.D., učo 11088. Changed: 8/7/2009 10:38. |
Abstract |
---|
Here, we summarize the current knowledge about the Frizzled receptors. We aim to analyze recent advantages about the mechanism of action, ligands and pharmacological properties of this receptor family. |
Abstract (in Czech) |
---|
Článek shrnuje současné poznání o receptorech Frizzled. V práci se snažíme zanalyzovat současné poznatky o mechanismu fungování těchto receptorů, o jejich ligandech a farmakologických vlastnostech. |
Links | |
---|---|
MSM0021622430, plan (intention) | Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie |
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies |
PrintDisplayed: 6/9/2024 05:16